for adult patients and an estimated attributable mortality of 10% [3] [4] [5] [6] [7] [8] [9] . Thus, VAP is considered to be an important cause of infection-related death and morbidity in ICUs [10] [11] [12] [13] [14] [15] [16] .
Focused training of health care workers to prevent VAP is essential in all ICUs, particularly in ICUs in resource-limited countries. Several investigators have reported an association between inadequate ICU staffing and the occurrence of nosocomial infections [17] [18] [19] [20] . Although the optimal approach for reducing the rate of VAP remains unclear, previous studies indicate that educating health care workers about how to prevent VAP and implementing policies and procedures to improve ventilator care can decrease rates of VAP [21] [22] [23] [24] [25] [26] . However, none of these studies have evaluated the Table 1 . Definition of ventilator-associated pneumonia in adults.
Criteria group Description 1
Patient has rales or dullness to percussion on physical examination of the chest and at least 1 of the following: (1) new onset of purulent sputum or change in character of sputum, (2) organism isolated from blood culture, or (3) isolation of pathogen from a specimen obtained by BAL, transtracheal aspiration, bronchial brushing, or biopsy 2
Patient has chest radiograph findings showing new or progressive infiltrates, consolidation, cavitation, or pleural effusion that persists for 148 h and at least 1 of the following: (1) new onset of purulent sputum or change in character of sputum, (2) organism isolated from blood culture, (3) isolation of pathogen from a specimen obtained by BAL, transtracheal aspiration, bronchial brushing, or biopsy, (4) isolation of virus or detection of viral antigen in respiratory secretions, (5) diagnostic single antibody titer (IgM) or 4-fold increase in paired sera (IgG) for pathogen, or (6) histopathologic evidence of pneumonia 3 Patient has chest radiograph findings showing new or progressive infiltrates, consolidation, cavitation, or pleural effusion that persists for 148 h and the following 2 criteria: (1) temperature, 138؇C; and (2) WBC count 110,000 cells/mL NOTE. Patients must meet at least 1 of the 3 criteria groups. From Garner et al. [28] . BAL, bronchoalveolar lavage.
long-term impact of these educational programs on ICU outcomes. To determine the long-term effect of an educational intervention to prevent VAP in a medical ICU (MICU), we performed a 4-year controlled, prospective, quasi-experimental study in a Thai tertiary care center. The model intervention for prevention of VAP used in this study had previously been shown to be effective in reducing rates of VAP in US hospitals [25, 26] . The intervention was performed in the MICU; the SICU and CCU served as control units. During the entire study period, no other protocols aimed at influencing the rates of VAP were introduced in the units. The same protocol for weaning patients off mechanical ventilation was used by nurses and respiratory therapists in all ICUs throughout the study. This weaning protocol was adapted from methods described by Kollef et al. [27] . The medical and nursing leadership of each ICU and the patient-to-nurse ratio of 2:1 remained constant throughout the entire study. Overall, there was limited turnover among the respiratory therapists and nursing staff in the ICUs (р15% during the entire study period). The hospital institutional review board approved this study. Definition and data collection. The VAP definition was derived from US Centers for Disease Control and Prevention definitions (table 1) [28] . Bacterial isolation and antimicrobial susceptibility testing were performed in accordance with Clinical Laboratory Standards Institute methodology [29] . In all of the ICUs, VAP was prospectively tracked by the same infection control specialist throughout the study, and the incidence of VAP was expressed as cases of VAP per 1000 ventilator-days. The patient data collected included demographic characteristics, underlying diseases, severity of illness (APACHE II score), results of culture of tracheal aspirate specimens, duration of mechanical ventilation, duration of hospital stay, processes of care (e.g., emptying of ventilator circuit condensate) and occurrence of VAP, crude mortality, cost of antibiotics to treat VAP, and the cost of hospitalization. The use of antibiotics to treat VAP was determined by chart reviews conducted by an infectious diseases physician after excluding other possible indications. Processes of care were abstracted from nursing and respiratory records. Costs, rather than charges, were used for each patient. Costs for hospitalization were estimated using available programmatic, personnel, pharmacy, and laboratory data. Hospital costs were estimated from the Thai insurance and hospital reimbursement systems. Laboratory diagnostic costs for each patient were obtained from line-item reports from the hospital's reimbursement system. The cost of antibiotics was calculated on the basis of the actual dosage given to the patients and was based on the purchase price to the institution, without including administration costs. All costs were converted to US dollars (40 Thai US$). . All patients admitted to all ICUs were observed during the entire study. The intervention team included a representative from hospital administration, an infectious diseases physician, a clinical microbiologist, an MICU attending physician and chief nurse, 2 infection control specialists, and a hospital epidemiologist.
METHODS

Setting and patients.
The centerpiece of the educational program was a previously validated 10-page self-study module [25, 26] . The module included information on the following topics related to VAP: (1) epidemiology and scope of the problem, (2) risk factors, (3) etiology, (4) definitions, (5) methods to decrease risk, (6) procedures for collecting suctioned sputum specimens, and (7) clinical and economic outcomes influenced by VAP. Risk factors for VAP that were specifically addressed included those resulting in aspiration (e.g., supine positioning and gastric overdistension) and those associated with bacterial colonization of the upper airway and stomach (e.g., prior antibiotic exposure and the use of prophylaxis for stress ulcers). The points made in the module were summarized with the acronym "WHAP VAP," in which W stood for "wean the patient as soon as possible," H for "hand hygiene," A for "aspiration precautions," and P for "prevent contamination." This acronym was also used on posters and fact sheets posted in the MICU. Fact sheets and posters were posted only in the MICU. No intervention was performed in the SICU and CCU. The educational program was repeated every 6 months for all nursing and respiratory staff during periods 2 and 3.
Before receiving the self-study module, participants were required to undergo a 20-question examination testing their baseline knowledge of VAP. An identical examination was given after the completion of the module. Participants who scored !80% on the postintervention test were required to repeat the module. In addition to the self-study module, the intervention included posters, fact sheets, and in-service training sessions for staff nurses and respiratory therapists. The in-service sessions were provided by an infectious diseases specialist (A.A.) and focused on VAP prevention practices. In-service sessions were provided during the first 3 months of the intervention during scheduled training time and staff meetings to gain access to the majority of nursing and respiratory therapy staff. They were repeated at month 6 and then every 6 months thereafter. The self-study module was encouraged for all respiratory care therapists and nurses working in the MICU. For MICU staff not participating in the formal self-study module, attendance at the scheduled in-service sessions, review of educational posters, and interaction with the MICU infection control specialist were encouraged to promote acceptance of the guidelines aimed at preventing VAP. Examinations were administered only to staff completing the self-study module.
To evaluate the microbiological pattern of bacterial resistance associated with VAP during the study periods, we tracked certain important and prevalent multidrug-resistant species detected during the baseline period for analysis. These included methicillin-resistant Staphylococcus aureus, extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae, and multidrug-resistant Acinetobacter baumannii. In this institution, standard precautions and contact isolation are used to prevent nosocomial transmission of drug-resistant microorganisms. If an outbreak due to multidrug-resistant grampositive or gram-negative bacteria occurs, additional interventions, including environmental cleaning with disinfectants and active surveillance for the particular drug-resistant microorganism, are implemented, as recommended by the hospital infection control unit.
Statistical analysis. Categorical variables were compared using the x 2 test or Fisher's exact test, as appropriate. Continuous variables were expressed as . Student's t test means ‫ע‬ SDs was used to compare continuous variables. Trend analysis was performed to evaluate the overall pattern of changes on outcomes of interest over time using interrupted time series with segmented regression analysis performed on SPSS, version 11.0 (SPSS). All tests were 2-tailed.
was considered to be P ! .05 statistically significant.
RESULTS
Patient demographic characteristics.
There were 5412 patients enrolled during the study (1904 patients in the MICU, 1805 in the SICU, and 1703 in the CCU). The mean age was 52 years (range, 15-89 years), and 2689 patients (50%) were female. The patient characteristics, sources of patients, time of VAP onset, number of ventilator-days, processes of care, antimicrobial therapy prior to VAP onset, and microorganisms associated with VAP are summarized in table 2. There were no significant differences in patient characteristics, underlying diseases, or severity of illness from one study period to the next. There were also no significant differences in the distribution of key patient characteristics, underlying diseases, severity of illness, and microorganisms associated with VAP among the 3 participating ICUs.
Test results. Thirty-two MICU health care workers (28 nurses and 4 respiratory therapists) completed the entire education module, with both the pre-and postintervention tests. Twenty-six MICU nurses and 4 respiratory therapists also com- pleted the module every 6 months after the intervention during period 3. Five MICU health care workers (4 nurses and 1 respiratory therapist) resigned from their positions and were not available for semiannual testing during period 3. The mean percentage of correct answers on the preintervention test was . These scores increased on the postintervention 78.5% ‫ע‬ 10.2% test to during period 2 ( ). Among 30 90.8% ‫ע‬ 7.1% P ! .001 health care workers, 28 (93%) had the same or higher scores on their postintervention tests in period 3. Two nurses (7%) had a decrease in the percentage of answers correct on their ), and the rate of VAP remained stable in the P p .001 SICU (5.6 cases per 1000 ventilator-days;
) and CCU P p .22 (4.8 cases per 1000 ventilator-days;
). Sustained reduc-P p .48 tions in the VAP rate in the MICU occurred during period 3 (4.2 cases per 1000 ventilator-days;
), but there was no P p .07 change in VAP rates in the SICU (5.5 cases per 1000 ventilatordays;
) and CCU (4.6 cases per 1000 ventilator-days; P p .82
). Rates of VAP in the individual ICUs are shown in P p .20 table 3. Segmented regression analysis showed a significant negative slope in the VAP rates in the MICU during period 2, compared with period 1, but there was no significant change in the y-intercept for VAP rates in the MICU between periods 1 and 2 (table 4) . Notably, the slope reductions in the VAP rates in the MICU approached statistical significance during period 3, compared with period 2 (table 4). The total mean duration of hospital stay in period 1 ( days) was also 14 ‫ע‬ 6.4 significantly reduced in periods 2 ( days; ) and 5.5 ‫ע‬ 3.6 P ! .001
( days;
). There was no difference in mor-5.1 ‫ע‬ 3.5 P ! .001 tality rates during the 3 periods (table 3) .
The pattern of microorganisms isolated from patients with VAP is shown in table 2. Notably, there was a monoclonal outbreak of Acinetobacter infection in the MICU during period 3. This outbreak was eliminated with intervention from the infection control unit, with the implementation of environmental cleaning and isolation procedures.
Cost of hospitalization and cost of antibiotics for treatment of VAP. The intervention resulted in a significant reduction in the total cost of antibiotics used to treat VAP and the cost of hospitalization in the MICU but not in control units (table  3) . Compared with costs in period 1, the monthly hospital antibiotic costs of VAP treatment and the hospitalization costs for each patient in the MICU in periods 2 and 3 were reduced by 45%-50% (mean cost of antibiotics and hospitalization, $4769 vs. $2622 vs. $2378;
) and 37%-45% (mean cost P ! .001 of antibiotics and hospitalization, $466 vs. $293 vs. $254; P ! ), respectively. .001
DISCUSSION
This study demonstrates that an educational program directed at respiratory care practitioners and intensive care unit nurses can dramatically decrease the long-term incidence of VAP, duration of hospital stay, hospital cost of antibiotics for VAP treatment, and cost of hospitalization. This intervention was relatively easy to implement, did not require the purchase of expensive technologies, and was highly effective in a 450-bed hospital in a developing country. Despite several reports that have shown effective interventions to prevent VAP [8, 30, 31] , these interventions are not being widely implemented. Cook et al. [32] compared Canadian ICUs with French ICUs with regard to the use of 7 strategies to prevent VAP and reduce overall health care costs. Adherence to specific VAP prevention guidelines was more common among French ICUs (64% vs. 30%; ) but was low in P p .002 both countries. A similar survey from Europe found that 37% of ICU practitioners were not observing published recommendations for the prevention of VAP [33] . The most common reasons for nonadherence were disagreement with the interpretation of clinical trials (35%), lack of resources (31.3%), and costs associated with the implementation of specific interventions (16.9%).
Educational interventions provide another attractive strategy for preventing VAP. Joiner et al. [21] assembled a multidisciplinary team to develop educational strategies involving medical, nursing, and respiratory therapy staff to reduce the cases of VAP in a 540-bed acute care medical center. This intervention prevented 18 cases of lower respiratory tract infection, with an estimated cost savings of $126,000. Kelleghan et al. [22] used continuous quality improvement concepts to create a multidisciplinary nosocomial pneumonia prevention team. They observed a 57% reduction in VAP rates after the implementation of the intervention, resulting in cost savings of $105,000 [22] . Similarly, members of our group reported the effect of an educational intervention at a large US teaching hospital and a large community hospital, where the resulting estimated cost savings was at least $425,666 [25, 26] . Factors associated with some of these successes included the active participation of respiratory therapists and key members of ICU leadership, including physicians and nurses; the use of evidence-based educational programs; and continuous monitoring of VAP nursing care practices to prevent VAP [21] [22] [23] [24] [25] [26] [34] [35] [36] [37] . The findings of our study and others emphasize the importance of improving ventilator management and care, rather than eliminating a particular nosocomial reservoir of infection.
Although educational interventions have been previously reported to help reduce VAP rates in ICUs [21] [22] [23] [24] [25] [26] [34] [35] [36] [37] , no studies have been conducted to evaluate the long-term effect of these interventions. Moreover, the impact of educational interventions on outcomes, such as duration of hospital stay, hospital cost of antibiotics for VAP treatment, and cost of hospitalization, are unknown. To our knowledge, this is the first study to demonstrate the 3-year effect of an educational intervention to reduce VAP rates, duration of hospital stay, hospital costs of antibiotics for VAP treatment, and cost of hospitalization. Our findings from the segmented time-series analysis are consistent with a gradual change in practice over time, resulting in a gradual decrease in infection rates over time, as supported by the incremental increase in the postintervention test score during periods 2 and 3.
There are several limitations to this study. This was not a randomized trial; thus, other unmeasured factors might have coincided with the intervention, resulting in lower VAP rates. However, this was not likely, because there was no change in VAP rates in the 2 control ICUs (SICU and CCU), and the characteristics and severity of illness among patients were com-parable during all of the study periods. Use of the self-study module and educational materials may also have resulted in other changes in behavior, in addition to those directly encouraged by the initiative, which could have accounted for these results. Although this is possible, the end result of a reduction in the VAP rate appears to be temporally associated with implementation of this intervention, as suggested by the ongoing declining slope over time from our interrupted time-series analysis. We recognize that the Centers for Disease Control and Prevention definition for VAP was not specific; however, this definition is commonly used in hospitals and allows ready comparison among institutions. Finally, because this intervention was performed at a single medical center, these results may not be applicable to other hospitals. However, the achievement of a similar effect in multiple settings suggests that the intervention may be generalizable to other facilities, particularly in developing countries.
Despite these limitations, our study has broadened the support for the efficacy of educational interventions to prevent VAP. Despite the emphasis that has been placed on guidelines to prevent VAP, a large discrepancy still exists at many institutions between published guidelines and actual practices. This may be accounted for by the lack of motivation on the part of hospitals to invest resources into successful implementation of guidelines or lack of dissemination of guidelines to front-line staff. By instituting this relatively easy, inexpensive intervention, we decreased VAP rates by 59%. This intervention was associated with a long-term sustained reduction in VAP rates, duration of hospital stay, antibiotic cost for VAP treatment, and cost of hospitalization. This intervention did not require expensive technology, which is a particularly important factor in developing countries.
